e-Article
A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer
Document Type
Article
Author
Source
In Clinical Genitourinary Cancer December 2013 11(4):477-483
Subject
Language
ISSN
1558-7673